(Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 95.59%-19.46M | -313.55%-952.13M | -203.13%-441.48M | -86.64%445.86M | 116.88%428.07M | 148.18%3.34B | -71.24%197.37M | 157.06%1.34B | 211.66%686.39M | 36.54%523.15M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 55.89%-49.49M | ---- | 31.15%-112.17M | ---- | 53.61%-162.93M | ---- | 14.57%-351.26M | ---- | -268.40%-411.19M |
Attributable subsidiary (profit) loss | ---- | -55.88%192.09M | ---- | 179.29%435.4M | ---- | 207.67%155.9M | ---- | -1,234.77%-144.8M | ---- | --12.76M |
Impairment and provisions: | --0 | 122.21%463.61M | --0 | -81.16%208.64M | --0 | 452.84%1.11B | --0 | 5,372.33%200.3M | --0 | 85.56%-3.8M |
-Impairment of property, plant and equipment (reversal) | ---- | --428.08M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of goodwill | ---- | ---- | ---- | 1.12%128.29M | ---- | --126.88M | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | -55.78%35.53M | ---- | -91.81%80.34M | ---- | 389.50%980.45M | ---- | 5,372.33%200.3M | ---- | 85.56%-3.8M |
Revaluation surplus: | --0 | -34.92%-125.04M | --0 | 68.16%-92.68M | --0 | 72.96%-291.06M | --0 | -45.30%-1.08B | --0 | -3,308.95%-740.87M |
-Fair value of investment properties (increase) | ---- | 337.47%184.46M | ---- | -179.89%-77.68M | ---- | 125.26%97.23M | ---- | -37.94%-384.87M | ---- | -547.35%-279.01M |
-Derivative financial instruments fair value (increase) | ---- | -205.50%-122.53M | ---- | 666.87%116.15M | ---- | 29.68%-20.49M | ---- | -1,190.39%-29.14M | ---- | -110.57%-2.26M |
-Other fair value changes | ---- | -42.57%-186.97M | ---- | 64.34%-131.15M | ---- | 44.48%-367.8M | ---- | -44.15%-662.51M | ---- | ---459.6M |
Asset sale loss (gain): | --0 | 90.42%-2.84M | --0 | 98.55%-29.63M | --0 | ---2.05B | --0 | --0 | --0 | --0 |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | 98.37%-33.18M | ---- | ---2.04B | ---- | ---- | ---- | ---- |
-Loss (gain) from selling other assets | ---- | -179.88%-2.84M | ---- | 143.12%3.55M | ---- | ---8.24M | ---- | ---- | ---- | ---- |
Depreciation and amortization: | --0 | 157.20%44.85M | --0 | 42.67%17.44M | --0 | 95.04%12.22M | --0 | -9.68%6.27M | --0 | -12.73%6.94M |
-Depreciation | ---- | 175.87%43.36M | ---- | 47.52%15.72M | ---- | 129.71%10.65M | ---- | 70.70%4.64M | ---- | -22.97%2.72M |
-Amortization of intangible assets | ---- | -13.31%1.49M | ---- | --1.72M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other depreciation and amortization | ---- | ---- | ---- | ---- | ---- | -3.68%1.57M | ---- | -61.42%1.63M | ---- | -4.57%4.22M |
Financial expense | ---- | -15.93%1.27B | ---- | -0.43%1.51B | ---- | 0.89%1.52B | ---- | 20.43%1.5B | ---- | 32.94%1.25B |
Exchange Loss (gain) | ---- | 87.78%-5.35M | ---- | -268.24%-43.76M | ---- | --26.01M | ---- | ---- | ---- | ---- |
Special items | -11.76%944.47M | 153.43%82.34M | 287.11%1.07B | -282.17%-154.11M | -2,872.27%-572.03M | --84.6M | 100.65%20.63M | ---- | ---3.16B | ---- |
Operating profit before the change of operating capital | 47.09%925.02M | -57.99%918.16M | 536.82%628.86M | -41.57%2.19B | -166.04%-143.96M | 152.31%3.74B | 108.80%218.01M | 133.20%1.48B | -1,224.50%-2.48B | -39.79%635.8M |
Change of operating capital | ||||||||||
Developing property (increase)decrease | ---- | 127.89%178.25M | ---- | -130.04%-639.02M | ---- | 321.22%2.13B | ---- | 275.44%505.01M | ---- | 482.70%134.51M |
Accounts receivable (increase)decrease | ---- | 192.91%1.13B | ---- | 80.61%-1.22B | ---- | -358.55%-6.28B | ---- | -105.14%-1.37B | ---- | 57.42%-668.06M |
Accounts payable increase (decrease) | ---- | -2,203.07%-440.46M | ---- | 80.80%-19.13M | ---- | -19,000.19%-99.6M | ---- | 100.44%527K | ---- | -126.85%-119.62M |
prepayments (increase)decrease | ---- | -19.10%585.03M | ---- | 264.65%723.13M | ---- | 477.43%198.31M | ---- | -10,366.53%-52.54M | ---- | ---502K |
Cash from business operations | 47.09%925.02M | 28.52%2.34B | 536.82%628.86M | 245.41%1.82B | -166.04%-143.96M | -471.41%-1.25B | 108.80%218.01M | 864.73%337.29M | -1,199.32%-2.48B | -107.56%-44.11M |
Other taxs | 45.91%-9.24M | 41.26%-38.22M | 70.70%-17.08M | 40.62%-65.06M | -26.58%-58.28M | 20.90%-109.56M | 54.53%-46.05M | 26.38%-138.52M | -89.47%-101.28M | 33.97%-188.15M |
Interest paid - operating | ---- | ---- | ---- | ---- | ---- | ---- | 5.60%-705.66M | -20.51%-1.49B | -14.36%-747.54M | -27.75%-1.24B |
Special items of business | ---- | -104.04%-31.86M | ---- | 184.40%789.33M | ---- | -310.35%-935.26M | ---- | -768.91%-227.92M | ---- | -103.82%-26.23M |
Net cash from operations | 49.69%915.78M | 31.11%2.3B | 402.49%611.79M | 228.94%1.76B | 62.10%-202.25M | -5.10%-1.36B | 83.95%-533.7M | 11.99%-1.3B | -270.42%-3.33B | -118.88%-1.47B |
Cash flow from investment activities | ||||||||||
Interest received - investment | -81.76%9.77M | -12.49%74.28M | -35.80%53.56M | -47.51%84.88M | 64.23%83.44M | -60.29%161.72M | -81.35%50.81M | 129.64%407.28M | 303.71%272.38M | 60.78%177.36M |
Restricted cash (increase) decrease | -92.85%14.05M | 66.20%521.53M | 504.18%196.4M | 161.00%313.79M | 117.52%32.51M | -245.81%-514.38M | ---185.57M | 75.85%-148.75M | ---- | ---615.95M |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | 490.18%948.9M | -3,371.82%-3.6B | -95.71%160.78M | -90.54%110.05M | 423.21%3.74B |
Decrease in deposits (increase) | ---- | 322.98%892.75M | 5,272.49%892.75M | -85.32%211.06M | -98.59%16.62M | -51.78%1.44B | -49.18%1.18B | 236.38%2.98B | 230.89%2.33B | -10,555.08%-2.19B |
Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 300.00%8K |
Purchase of fixed assets | 87.46%-140K | 99.72%-1.18M | 97.71%-1.12M | -3,940.84%-418.87M | -2,673.68%-48.68M | 82.23%-10.37M | 82.49%-1.76M | 48.45%-58.35M | -10,229.90%-10.02M | -67.17%-113.18M |
Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2,459.39%-11.72M | ---- | -31.23%-458K |
Sale of subsidiaries | ---- | ---- | ---- | -98.11%32.53M | -17.86%1.36B | --1.73B | --1.65B | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | 43.83%-650.3M | 43.91%-649.47M | ---1.16B | ---1.16B | ---- | ---- | -2,907.44%-2B |
Recovery of cash from investments | ---- | -83.11%419.23M | -87.34%177.04M | 44.05%2.48B | 436.59%1.4B | 78.32%1.72B | -11.75%260.51M | 160.58%966.37M | 2,386.44%295.22M | -13,421.64%-1.6B |
Cash on investment | ---- | ---- | ---- | 641.46%706.77M | --660.29M | 103.39%95.32M | ---- | -16.84%-2.81B | -94.83%117.65M | -73.44%-2.41B |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | --957.88M | ---- | ---- | ---- |
Net cash from investment operations | -98.20%23.67M | -30.97%1.91B | -53.75%1.32B | -37.36%2.76B | 439.09%2.85B | 196.90%4.41B | -127.03%-840.85M | 129.73%1.49B | 78.69%3.11B | -96.87%-5B |
Net cash before financing | -51.33%939.45M | -6.84%4.21B | -27.13%1.93B | 48.28%4.52B | 292.72%2.65B | 1,511.95%3.05B | -539.32%-1.37B | 102.92%189.05M | -125.51%-215M | -101.49%-6.47B |
Cash flow from financing activities | ||||||||||
New borrowing | -95.73%117.14M | 149.60%3.91B | 524.73%2.75B | -75.19%1.57B | -84.97%439.62M | 47.58%6.31B | 295.93%2.93B | -41.47%4.28B | -75.45%738.92M | 41.28%7.31B |
Refund | 88.45%-423.2M | -76.90%-6.4B | -71.78%-3.66B | 57.12%-3.62B | -27.47%-2.13B | -69.81%-8.44B | -469.36%-1.67B | -121.49%-4.97B | 82.60%-293.89M | 14.73%-2.24B |
Issuing shares | ---- | ---- | ---- | --25.84M | --25.84M | ---- | ---- | ---- | ---- | ---- |
Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 113.31%800M |
Interest paid - financing | 12.46%-704.41M | 16.94%-1.42B | 14.13%-804.69M | -21.91%-1.71B | ---937.1M | ---1.4B | ---- | ---- | ---- | ---- |
Dividends paid - financing | ---- | ---- | ---- | ---722.56M | ---- | ---- | ---- | ---- | ---- | ---21.42M |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | --29.55M | --29.55M | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -0.02%-61.74M |
Other items of the financing business | 98.37%-2.54M | -648.59%-242.5M | -6,844.22%-156.11M | -123.70%-32.39M | 43.66%-2.25M | -58.17%136.66M | ---3.99M | -55.02%326.75M | ---- | 97,606.58%726.42M |
Net cash from financing operations | 46.07%-1.01B | 7.55%-4.15B | 27.94%-1.88B | -33.73%-4.49B | -303.99%-2.61B | -827.84%-3.36B | 187.14%1.28B | -105.56%-362.03M | -65.74%445.03M | 127.92%6.51B |
Effect of rate | 164.46%3.05M | -598.78%-9.02M | -170.65%-4.74M | -86.25%1.81M | 106.80%6.7M | 173.37%13.15M | -450.31%-98.61M | 93.50%-17.93M | 349.99%28.15M | -689.76%-275.92M |
Net Cash | -241.30%-73.56M | 113.09%56.65M | 23.38%52.06M | 108.53%26.59M | 143.65%42.2M | -80.16%-311.63M | -142.03%-96.68M | -511.98%-172.98M | -89.26%230.03M | 111.86%41.99M |
Begining period cash | 56.96%131.26M | 51.41%83.62M | 51.41%83.62M | -84.39%55.23M | -84.39%55.23M | -35.05%353.71M | -35.05%353.71M | -30.05%544.61M | -30.05%544.61M | -28.29%778.54M |
Cash at the end | -53.61%60.75M | 56.96%131.26M | 25.76%130.95M | 51.41%83.62M | -34.27%104.13M | -84.39%55.23M | -80.27%158.42M | -35.05%353.71M | -72.40%802.78M | -30.05%544.61M |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data